Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
glucagon-like peptide-1 (1 trial)
Cerebral Hemorrhage (Phase 2)
Hemorrhage (Phase 2)
Trials (1 total)
Trial APIs (1 total)